A Phase II combination trial with recombinant human tumor necrosis factor and gamma interferon in patients with colorectal cancer
- 1 April 1991
- journal article
- clinical trial
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 69 (6) , 261-268
- https://doi.org/10.1007/bf01666852
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Alpha‐globulins suppress human leukocyte tumor necrosis factor secretionEuropean Journal of Immunology, 1989
- Cooperative effect of interferon‐γ and tumor necrosis factor‐α on the induction of the class II antigen‐associated invariant chain expressionEuropean Journal of Immunology, 1988
- A human inhibitor of tumor necrosis factor alpha.The Journal of Experimental Medicine, 1988
- The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity.The Journal of Experimental Medicine, 1988
- Effect of tumor necrosis factor alpha on mitogen-activated human B cells.The Journal of Experimental Medicine, 1987
- Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.The Journal of Experimental Medicine, 1987
- Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1Nature, 1986
- Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factorsNature, 1986
- Tumor Necrosis Factor (TNF)Science, 1985
- Identity of tumour necrosis factor and the macrophage-secreted factor cachectinNature, 1985